Search for: "Johnson v. General Motors Corp." Results 81 - 100 of 115
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Jun 2019, 5:43 am by Joel R. Brandes
Corp. v. 2319 Richmond Terrace Corp., 141 A.D.3d 626, 627, 34 N.Y.S.3d 616).Oral promise to pay credit card bills during the pendency of action unenforceable            In Novick v Novick, ‑‑‑ N.Y.S.3d ‑‑‑‑, 2019 WL 2202438 (Mem), 2019 N.Y. [read post]
10 Jan 2013, 1:13 pm by John Elwood
United States, 12-357, the managing partner of a venture capital fund started threatening to tell the wife of the New York Comptroller General that he was cheating on her if the Comptroller General did not invest in his fund. [read post]
19 Jun 2015, 12:13 pm by John Elwood
   Dollar General Corp. v. [read post]
11 Jan 2015, 7:31 pm by Omar Ha-Redeye
 and the Court of Appeal’s decision in Johnson v. [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation… [read post]
3 Dec 2015, 1:26 pm by Beth Graham
Interstate/Johnson Lane Corp., 500 U.S. 20, 26 (1991) (quoting Mitsubishi Motors Corp., supra at 628. [read post]
15 Jan 2008, 3:06 am
General Motors Corporation et al filed 03/12/07 1:07-cv-01401 Acco Brands USA LLC v. [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its… [read post]
15 Feb 2007, 12:25 am
Suzuki Motor Corp., 996 S.W.2d 47, 63 (Mo. 1999); Marsh v. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007:… [read post]